Management of paracetamol poisoning

BMJ

Volumn 342, Issue 7804, 2011, Pages 968-972

  Ferner, Robin E ^a,b   Dear, James W ^c,d   Bateman, D Nicholas ^c  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CHARCOAL; PARACETAMOL;

ANAPHYLAXIS; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG INTOXICATION; DRUG METABOLISM; DRUG OVERDOSE; FLUID THERAPY; HUMAN; KIDNEY INJURY; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE DRUG DOSE; TOXICITY TESTING; TREATMENT INDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ACETAMINOPHEN; ACETYLCYSTEINE; AMBULATORY CARE; ANALGESICS, NON-NARCOTIC; ANTIDOTES; DRUG OVERDOSE; DRUG-INDUCED LIVER INJURY; HUMANS; LIVER TRANSPLANTATION; NOMOGRAMS; PHYSICAL EXAMINATION;

EID: 79955548741     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2218     Document Type: Review

References (36)

1. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Giffin SL. 2009 Annual Report of the American Association of Poison Control Centers' national poison data system (NPDS): 27th annual report. Clin Toxicol (Phila) 2010;48:979-1178.
2. Khan LR, Oniscu GC, Powell JJ. Long-term outcome following liver transplantation for paracetamol overdose. Transpl Int 2010;23:524-9.
3. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42:1364-72.
4. Pakravan N, Simpson K, Waring WS, Bates CM, Bateman DN. Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit. Eur J Clin Pharmacol 2009;65:163-8.
5. Prescott LF. Paracetamol (acetaminophen): a critical bibliographic review. 2nd ed. Taylor & Francis. 2001:587-88.
6. Hinson JA, Roberts DW, James LP. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol 2010;196:369-405.
7. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 2009;119:305-14.
8. Jones AF, Vale JA. Paracetamol poisoning and the kidney. J Clin Pharm Ther 1993;18:5-8. (Pubitemid 23061259)
9. Shah AD, Wood DM, Dargan PI. Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. Br J Clin Pharmacol 2010;71:20-8.
10. Beringer RM, Thompson JP, Parry S, Stoddart PA. Intravenous paracetamol overdose: two case reports and a change to national treatment guidelines. Arch Dis Child 2011;96:307-8.
11. Fernando WK, Ariyananda PL. Paracetamol poisoning below toxic level causing liver damage in a fasting adult. Ceylon Med J 2009;54:16-7.
12. Green TJ, Sivilotti ML, Langmann C, Yarema M, Juurlink D, Burns MJ, et al. When do the aminotransferases rise after acute acetaminophen overdose? Clin Toxicol (Phila) 2010;48:787-92.
13. Prescott LF, Roscoe P, Wright N, Brown S. Plasma paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1971;1:519-22.
14. Teece S, Hogg K. Best evidence topic reports. Gastric lavage in paracetamol poisoning. Emerg Med J 2004;21:75-6.
15. Chyka PA, Seger D, Krenzelok EP, Vale JA. Position paper: single-dose activated charcoal. Clin Toxicol (Phila) 2005;43:61-87.
16. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. BMJ 1979;2:1097-100.
17. eMC. Summary of product characteristics. Parvolex 200 mg/ml concentrate for solution for infusion. 2011. www.medicines.org.uk/EMC/medicine/1127/SPC/ Parvolex+200+mg+ml+Concentrate+for+Solution+for+Infusion/.
18. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988;319:1557-62. (Pubitemid 19003420)
19. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991;303:1026-9.
20. Yarema MC, Johnson DW, Berlin RJ, Sivilotti ML, Nettel-Aguirre A, Brant RF, et al. Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med 2009;54:606-14.
21. Boobis AR, Tee LB, Hampden CE, Davies DS. Freshly isolated hepatocytes as a model for studying the toxicity of paracetamol. Food Chem Toxicol 1986;24:731-6. (Pubitemid 17184058)
22. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975;55:871-6.
23. Daly FF, Fountain JS, Murray L, Graudins A, Buckley NA. Guidelines for the management of paracetamol poisoning in Australia and New Zealand - explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust 2008;188:296-301.
24. Bridger S, Henderson K, Glucksman E, Ellis AJ, Henry JA, Williams R. Deaths from low dose paracetamol poisoning. BMJ 1998;316:1724-5. (Pubitemid 28254428)
25. Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila) 2009;47:81-8.
26. Mant T, Tempowski J, Volans G, Talbot J. Adverse reactions to acetylcysteine and effects of overdose. BMJ 1984;289:217-9. (Pubitemid 14014338)
27. Waring WS, Stephen AF, Robinson OD, Dow MA, Pettie JM. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol (Phila) 2008;46:496-500. (Pubitemid 351913757)
28. Beer C, Pakravan N, Hudson M, Smith LT, Simpson K, Bateman DN, et al. Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds. QJM 2007;100:93-6. (Pubitemid 46332119)
29. Dalhoff K, Gesser K, Rasmussen M. Should you treat every paracetamol-poisoned patient? Clin Toxicol (Phila) 2009;47:440.
30. Craig DG, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 2010;31:1064-76.
31. Pearce B, Grant IS. Acute liver failure following therapeutic paracetamol administration in patients with muscular dystrophies. Anaesthesia 2008;63:89-91. (Pubitemid 350233217)
32. Flanagan RJ, de Wolff FA, Mills IM. Principles, practice and paracetamol: when units matter. Ann Clin Biochem 2000;37:16-9. (Pubitemid 30064221)
33. Ferner RE, Langford NJ, Anton C, Hutchings A, Bateman DN, Routledge PA. Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol 2001;52:573-7.
34. Tighe TV, Walter FG. Delayed toxic acetaminophen level after initial four hour nontoxic level. J Toxicol Clin Toxicol 1994;32:431-4. (Pubitemid 24269367)
35. Kerr F, Dawson A, Whyte IM, Buckley N, Murray L, Graudins A, et al. The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 2005;45:402-8. (Pubitemid 43181007)
36. Reid AB, Kurten RC, McCullough SS, Brock RW, Hinson JA. Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Ther 2005;312:509-16. (Pubitemid 40189547)